[go: up one dir, main page]

PL1808164T3 - Sposób z granulacją na mokro do wytwarzania kompozycji farmaceutycznych aripiprazolu - Google Patents

Sposób z granulacją na mokro do wytwarzania kompozycji farmaceutycznych aripiprazolu

Info

Publication number
PL1808164T3
PL1808164T3 PL06251324T PL06251324T PL1808164T3 PL 1808164 T3 PL1808164 T3 PL 1808164T3 PL 06251324 T PL06251324 T PL 06251324T PL 06251324 T PL06251324 T PL 06251324T PL 1808164 T3 PL1808164 T3 PL 1808164T3
Authority
PL
Poland
Prior art keywords
aripiprazole
pharmaceutical compositions
wet granulation
granulation method
preparing pharmaceutical
Prior art date
Application number
PL06251324T
Other languages
English (en)
Inventor
Julia Hrakovsky
Ruth Tenengauzer
Original Assignee
Teva Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36637023&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1808164(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Teva Pharma filed Critical Teva Pharma
Publication of PL1808164T3 publication Critical patent/PL1808164T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL06251324T 2006-01-05 2006-03-14 Sposób z granulacją na mokro do wytwarzania kompozycji farmaceutycznych aripiprazolu PL1808164T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75670806P 2006-01-05 2006-01-05
EP06251324.7A EP1808164B2 (en) 2006-01-05 2006-03-14 Wet granulation method for preparing pharmaceutical compositions of aripiprazole

Publications (1)

Publication Number Publication Date
PL1808164T3 true PL1808164T3 (pl) 2009-06-30

Family

ID=36637023

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06251324T PL1808164T3 (pl) 2006-01-05 2006-03-14 Sposób z granulacją na mokro do wytwarzania kompozycji farmaceutycznych aripiprazolu

Country Status (13)

Country Link
US (1) US8865722B2 (pl)
EP (2) EP2036545A1 (pl)
JP (1) JP4875001B2 (pl)
CN (1) CN101351192A (pl)
AT (1) ATE419837T1 (pl)
CA (1) CA2627693A1 (pl)
DE (1) DE602006004694D1 (pl)
DK (1) DK1808164T3 (pl)
ES (1) ES2318693T5 (pl)
IL (1) IL190916A0 (pl)
PL (1) PL1808164T3 (pl)
PT (1) PT1808164E (pl)
WO (1) WO2007081366A1 (pl)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI320783B (en) 2005-04-14 2010-02-21 Otsuka Pharma Co Ltd Heterocyclic compound
TR200604349A2 (tr) 2006-08-15 2008-03-21 NOBEL İLAÇ SANAYii VE TiCARET A.Ş. Aripiprazol içeren farmasötik bileşimler
GB0618879D0 (en) 2006-09-26 2006-11-01 Zysis Ltd Pharmaceutical compositions
WO2010079506A2 (en) 2008-06-23 2010-07-15 Torrent Pharmaceuticals Ltd. Pharmaceutical composition of aripiprazole
WO2011032882A1 (en) 2009-09-15 2011-03-24 Ratiopharm Gmbh Orally disintegrating pharmaceutical dosage form containing aripiprazole
CN102106826B (zh) * 2009-12-29 2013-06-05 上海中西制药有限公司 一种阿立哌唑固体制剂及其制备方法
HRP20150105T1 (hr) * 2010-04-30 2015-03-13 Bristol-Myers Squibb Company Farmaceutske kompozicije koje sadrže n-(4-(2-amino-3-hloropiridin-4-iloksi)-3-fluorofenil-l-(4-fluorofenil)-2-okso-1,2-dihidropiridin-3-karboksamid
CN102850268B (zh) * 2011-06-27 2015-07-15 上海中西制药有限公司 阿立哌唑ⅰ型微晶、阿立哌唑固体制剂及制备方法
JO3753B1 (ar) 2011-10-14 2021-01-31 Otsuka Pharma Co Ltd قرص يتألف من 7-[4-(4-بينزو[بي]ثيوفين-4-ايل-ببرازين-1-1ايل)بوتكسيل]-1اتش-كوينولين-2-وان أو ملح منه
US9717707B2 (en) * 2011-12-08 2017-08-01 Hexal Ag Pharmaceutical statin composition
WO2013100878A1 (en) * 2011-12-27 2013-07-04 Mahmut Bilgic Pharmaceutical formulations comprising aripiprazole
WO2014104989A1 (en) * 2011-12-27 2014-07-03 Mahmut Bilgic Pharmaceutical compositions comprising aripiprazole
WO2013175508A2 (en) 2012-05-24 2013-11-28 Medreich Limited Stable pharmaceutical composition of aripiprazole
JP6007169B2 (ja) * 2012-11-30 2016-10-12 大原薬品工業株式会社 アリピプラゾール無水物を含有する固形製剤の製造方法
EP2838513B1 (en) * 2013-04-30 2017-04-05 Otsuka Pharmaceutical Co., Ltd. Oral solid preparation comprising aripiprazole and method for producing oral solid preparation comprising aripiprazole
US9051268B2 (en) 2013-04-30 2015-06-09 Otsuka Pharmaceutical Co., Ltd. Oral solid preparation comprising aripiprazole and method for producing oral solid preparation comprising aripiprazole
GR1008442B (el) * 2014-01-16 2015-03-05 "Φαρματεν Α.Β.Ε.Ε.", Φαρμακευτικο σκευασμα περιεχον αριπιπραζολη ή αλας αυτης
EP3002005A1 (en) * 2014-09-30 2016-04-06 Molkerei Meggle Wasserburg GmbH & Co. Kg Direct compression excipient based on lactose, cellulose and starch
WO2016189504A1 (en) * 2015-05-28 2016-12-01 Leiutis Pharmaceuticals Pvt Ltd Non-lyophilized compositions of aripiprazole and methods of preparation thereof
US11672761B2 (en) 2020-11-16 2023-06-13 Orcosa Inc. Rapidly infusing platform and compositions for therapeutic treatment in humans
WO2022103636A1 (en) 2020-11-16 2022-05-19 Orcosa Inc. Improved use of cannabinoids in the treatment of alzheimer's disease

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA71629C2 (en) * 1999-08-03 2004-12-15 Lilli Icos Llc Composition containing free drug particulate form of ?-carboline (variants), method for its manufacture (variants), and method for treating sexual dysfunction
CA2311734C (en) 2000-04-12 2011-03-08 Bristol-Myers Squibb Company Flash-melt oral dosage formulation
US20020076437A1 (en) * 2000-04-12 2002-06-20 Sanjeev Kothari Flashmelt oral dosage formulation
MY129350A (en) 2001-04-25 2007-03-30 Bristol Myers Squibb Co Aripiprazole oral solution
AR033485A1 (es) * 2001-09-25 2003-12-26 Otsuka Pharma Co Ltd Sustancia medicinal de aripiprazol de baja higroscopicidad y proceso para la preparacion de la misma
TWI324074B (en) 2001-10-09 2010-05-01 Bristol Myers Squibb Co Flashmelt oral dosage formulation
JP2003238393A (ja) 2002-02-15 2003-08-27 Otsuka Pharmaceut Co Ltd 施錠性が改善された錠剤及びその製造方法
DE10224170A1 (de) * 2002-05-31 2003-12-11 Desitin Arzneimittel Gmbh Pharmazeutische Zusammensetzung mit verzögerter Wirkstofffreisetzung
US7491726B2 (en) 2003-03-21 2009-02-17 Hetero Drugs Limited Crystalline forms of aripiprazole
EP1618103A2 (en) 2003-04-25 2006-01-25 Cadila Healthcare Ltd. Polymorphs of aripiprazole
JP2007509155A (ja) 2003-10-21 2007-04-12 アルファーマ インコーポレイテッド クエチアピンを含有する薬剤
AU2004285448C1 (en) 2003-10-23 2021-08-19 Otsuka Pharmaceutical Co., Ltd. Controlled release sterile injectable aripiprazole formulation and method
JP5546717B2 (ja) * 2003-12-16 2014-07-09 テバ ファーマシューティカル インダストリーズ リミティド アリピプラゾール結晶質形態を調製する方法
WO2005067976A2 (en) * 2004-01-20 2005-07-28 Novartis Ag Direct compression formulation and process
US7507823B2 (en) 2004-05-06 2009-03-24 Bristol-Myers Squibb Company Process of making aripiprazole particles
WO2006053780A1 (en) 2004-11-18 2006-05-26 Synthon B.V. Crystalline aripiprazole solvates
CN102627603A (zh) 2004-11-18 2012-08-08 斯索恩有限公司 制备结晶阿立哌唑的方法
EP1686117A1 (en) 2005-01-27 2006-08-02 Sandoz AG Polymorph and solvates of aripiprazole
EP1858514B1 (en) 2005-03-17 2014-11-26 Synthon B.V. Pharmaceutical tablets of crystalline type ii aripiprazole
CA2605128A1 (en) 2005-04-15 2007-01-11 Medichem, S.A. Syntheses and preparations of polymorphs of crystalline aripiprazole
US20070014853A1 (en) 2005-07-15 2007-01-18 Ilan Zalit Pharmaceutical dosage form containing novel pharmaceutical granulate
US20070014864A1 (en) 2005-07-15 2007-01-18 Teva Pharmaceutical Industries, Ltd. Novel pharmaceutical granulate
CN101222911A (zh) 2005-07-15 2008-07-16 特瓦制药工业有限公司 新的制粒方法及由此制备的颗粒
US20070014854A1 (en) 2005-07-15 2007-01-18 Ilan Zalit Novel granulation process
JP2009508859A (ja) 2005-09-15 2009-03-05 エラン ファーマ インターナショナル リミテッド ナノ粒子アリピプラゾール製剤
US20070148245A1 (en) 2005-12-22 2007-06-28 Ilan Zalit Compressed solid dosage forms with drugs of low solubility and process for making the same
WO2007073389A1 (en) 2005-12-22 2007-06-28 Teva Pharmaceutical Industries Ltd. Compressed solid dosage forms with drugs of low solubility and process for making the same
JP2008537540A (ja) 2005-12-22 2008-09-18 テバ ファーマシューティカル インダストリーズ リミティド アリピプラゾールの粒径を小さくする方法
WO2007092779A2 (en) 2006-02-03 2007-08-16 Dr. Reddy's Laboratories Ltd. Aripiprazole co-crystals
EP1880714A1 (en) 2006-07-20 2008-01-23 Helm AG Amorphous Aripiprazole and Process for the Preparation thereof

Also Published As

Publication number Publication date
EP2036545A1 (en) 2009-03-18
EP1808164A1 (en) 2007-07-18
JP4875001B2 (ja) 2012-02-15
IL190916A0 (en) 2008-11-03
ATE419837T1 (de) 2009-01-15
US20070154544A1 (en) 2007-07-05
EP1808164B2 (en) 2018-07-04
ES2318693T5 (es) 2018-10-04
US8865722B2 (en) 2014-10-21
JP2008531737A (ja) 2008-08-14
DK1808164T3 (da) 2009-04-20
PT1808164E (pt) 2009-03-17
CN101351192A (zh) 2009-01-21
WO2007081366A1 (en) 2007-07-19
CA2627693A1 (en) 2007-07-19
DE602006004694D1 (de) 2009-02-26
ES2318693T3 (es) 2009-05-01
EP1808164B1 (en) 2009-01-07

Similar Documents

Publication Publication Date Title
IL190916A0 (en) Wet granulation pharmaceutical compositions of aripiprazole
ZA200710734B (en) Compositions for drug delivery
PT3984528T (pt) Composições farmacêuticas que compreendem nilotinib
AP2384A (en) 1,2,4,5-tetrahydro-3H-benzazepine compounds, a process for their preparation and pharmaceutical compositions containing them.
GB0608820D0 (en) Pharmaceutical compounds
IL194961A0 (en) Compounds a-r-x for the manufacture of pharmaceutical preparations
IL190915A0 (en) Dry formulations of aripiprazole
AP2010005343A0 (en) New dihydroindolone compounds, a process for theirpreparation and pharmaceutical compositions conta ining them.
IL188069A0 (en) Process for preparing new tiotropium salts, new tiotropium salts as such and pharmaceutical compositions thereof
EP1871363A4 (en) COMBINED STAGE PROCESS FOR PHARMACEUTICAL COMPOSITIONS
PL1844036T3 (pl) Sposób otrzymywania arypiprazolu
IL205952A0 (en) Protease variants for pharmaceutical use
IL198160A0 (en) Pharmaceutical formulations
ZA200806399B (en) Novel pyridinylaminoalkylene- and pyridinyloxyalkylene-cyclopropanamines, process for the preparation thereof and pharmaceutical compositions containing them
IL192963A0 (en) Rimonabant monohydrate, process for the preparation thereof and pharmaceutical compositions containing same
GB0608176D0 (en) Pharmaceutical Compounds
ZA200805656B (en) Prodrug ER²-selective substances, methods for the production thereof and pharmaceutical compositions containing said compounds
GB0608184D0 (en) Pharmaceutical compounds
GB0608264D0 (en) Pharmaceutical compounds
GB0608175D0 (en) Pharmaceutical Compounds
GB0617966D0 (en) Novel 2 amino-pyrimidine derivatives, processes for preparing them, pharmaceutical compositions thereof
IL193450A0 (en) A gastro-retentive system for the delivery of macromolecules
GB0519083D0 (en) Compositions for the improved delivery of medicaments
GB0615461D0 (en) Pharmaceutical formulations
AU2007902087A0 (en) Proprietary brand fragrance delivery method for clothing